Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Leveraging Artificial Intelligence and Multi-Omics Data to Predict Opioid Addiction — Stella

Home/Opioid Use Disorder/Leveraging Artificial Intelligence and Multi-Omics Data to Predict Opioid Addiction

View on ClinicalTrials.gov

Recruiting

Back to Opioid Use Disorder trials

Leveraging Artificial Intelligence and Multi-Omics Data to Predict Opioid Addiction

Trial locations(1 site)

United States

University of California, San Diego, La Jolla, California

Key details

Sponsor

University of California, San Diego

Collaborators

VA Palo Alto Health Care System, San Diego Veterans Healthcare System

Enrollment target

~300 participants

Started

August 2024

Primary completion

June 2027

Age range

18 Years and older

Last updated September 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.